Market

Quarterly Results

You can view the Quarterly Results for the last 5 years.

QUARTERLY RESULTS

Alembic Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 15412.51 P/BV 2.83 Book Value ( ₹ ) 277.42
52 Week High/Low ( ₹ ) 1108/636 FV/ML 2/1 P/E(X) 22.84
Book Closure 29/07/2025 EPS ( ₹ ) 34.33 Div Yield (%) 0.00
(₹ in Crs.)

ParticularsMar 26Dec 25Sep 25Jun 25Mar 25
Net Sales/Income from operations1847.721876.311910.151710.721769.64
Total Income From Operations1847.721876.311910.151710.721769.64
      
EXPENDITURE     
Consumption of Raw Materials404.24448.73463.14431.27426.20
Purchase of Traded Goods129.79143.11126.82109.1692.64
Increase/Decrease in Stocks-1.88-62.87-74.04-133.0211.77
Employees Cost438.91432.71437.54422.77393.59
Depreciation88.5980.1276.0773.7768.99
Other Expenses648.74621.14641.00599.19573.51
Total Expenses1708.391662.941670.531503.141566.70
      
P/L Before Other Inc. , Int., Excpt. Items & Tax139.33213.37239.62207.58202.94
Other Income25.5015.506.916.5014.19
P/L Before Interest, Excpt. Items & Tax164.83228.87246.53214.08217.13
Interest22.5623.3124.2323.5224.52
P/L Before Exceptional Items & Tax142.27205.56222.30190.56192.61
Exceptional Items-24.76-42.230.000.000.00
P/L Before Tax117.51163.33222.30190.56192.61
Tax-82.9129.5440.0136.4835.32
P/L After Tax from Ordinary Activities200.42133.79182.29154.08157.29
Net Profit/Loss For the Period200.42133.79182.29154.08157.29
Minority Interest1.171.021.000.750.26
Share Of P/L Of Associates1.11-1.841.42-0.45-0.66
Net P/L After Minority Interest & Share Of Associates202.70132.97184.71154.38156.89
      
Equity Share Capital39.3139.3139.3139.3139.31
EPS Before Extra Ordinary *     
Basic EPS (Rs.)10.316.769.407.857.98
Diluted EPS (Rs.)10.316.769.407.857.98
EPS After Extra Ordinary *     
Basic EPS (Rs.) 10.316.769.407.857.98
Diluted EPS (Rs.) 10.316.769.407.857.98
      
PBITOE Margin (%)7.5411.3712.5412.1311.46
PBTE Margin (%)7.6910.9511.6311.1310.88
PBT Margin (%)6.358.7011.6311.1310.88
PAT Margin (%)10.847.139.549.008.88
PAT After MI And SOA Margin (%)10.977.089.669.028.86
ParticularsMar 26
Net Sales/Income from operations1847.72
Total Income From Operations1847.72
  
EXPENDITURE 
Consumption of Raw Materials404.24
Purchase of Traded Goods129.79
Increase/Decrease in Stocks-1.88
Employees Cost438.91
Depreciation88.59
Other Expenses648.74
Total Expenses1708.39
P/L Before Other Inc. , Int., Excpt. Items & Tax139.33
Other Income25.50
P/L Before Interest, Excpt. Items & Tax164.83
Interest22.56
P/L Before Exceptional Items & Tax142.27
Exceptional Items-24.76
P/L Before Tax117.51
Tax-82.91
P/L After Tax from Ordinary Activities200.42
Net Profit/Loss For the Period200.42
Minority Interest1.17
Share Of P/L Of Associates1.11
Net P/L After Minority Interest & Share Of Associates202.70
Equity Share Capital39.31
EPS Before Extra Ordinary * 
Basic EPS (Rs.)10.31
Diluted EPS (Rs.)10.31
EPS After Extra Ordinary * 
Basic EPS (Rs.) 10.31
Diluted EPS (Rs.) 10.31
PBITOE Margin (%)7.54
PBTE Margin (%)7.69
PBT Margin (%)6.35
PAT Margin (%)10.84
PAT After MI And SOA Margin (%)10.97
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.